Video Player is loading.
Current Time 0:00
Duration 0:06
Loaded: 0.00%
Stream Type LIVE
Remaining Time 0:06
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected
    PRICING AND MARKET ACCESS

    Optimize patient value and access

    IQVIA Value and Access (V&A) Strategy Consulting helps you define and defend product value across the entire lifecycle. Our customized solutions and proprietary tools support enhanced access to your treatments.

    2250+ PROJECTS COMPLETED

    425+ DRUG PRODUCTS

    325+ THERAPEUTIC AREAS

    250+ PRICING and MARKET ACCESS EXPERTS IN NETWORK

    IQVIA’s V&A Team can provide end-to-end support across the globe

    PEOPLE

    We help you discover unrealized connections and see solutions through the lens of insight, yielding and implementing breakthrough ideas


    EXPERTISE

    Our deep, global expertise spans clinical to commercial functions in multiple therapeutic areas and is powered by our highly-trained market access experts with global and local expertise


    CONNECTED CAPABILITIES

    Through proprietary data, technology, and advanced analytics and methodologies, we help you bring innovative therapies to patients

    Market Access

    Value and Access Strategy Consulting

    Support clients with a key strategic goal that underpins successful launches:

    Leverage evidence to drive patient access at a price that maximizes value for healthcare Stakeholders.

    Video Player is loading.
    Current Time 0:00
    Duration 0:00
    Loaded: 0%
    Stream Type LIVE
    Remaining Time 0:00
     
    1x
      • Chapters
      • descriptions off, selected
      • subtitles off, selected

        HTA Accelerator

        The Health Technology Assessment Accelerator (HTAA) from IQVIA allows the user to analyze past and current payer assessments and evidence requirements to guide clinical trial design and market access strategy across the product lifecycle.

        IQVIA HTAA is now bigger and better after our recent acquisition of Prism access and can offer best-in-class tools to boost your V&A strategy through its dashboards, allowing for quick display of regulatory, clinical, HTA, and pricing approaches/decisions

        Market Access Planning (MAP) Tool

        The Market Access Planning Platform (MAP) is a web-based, comprehensive solution to navigate the market access roadmap. It allows the user to create and monitor personalized market access plans for an entire global portfolio, while improving organizational communication and efficacy.

        IRP Tool

        Over time, International Reference Pricing (IRP) can have a serious impact on your business. IQVIA’s IRP tool not only assesses the impact of IRP rules by country, but it also allows you to run “what if” scenarios to understand the impact of different variables (referencing events, list/net price changes, volume adjustments, country of origin, etc.) on your optimal launch sequence, margins, and other key business decisions and metrics.

        E-Groups

        The IQVIA e-Group is a convenient, interactive, online research platform with the ability to gather qualitative feedback, post follow-up questions, and conduct exercises (e.g., polling, rating) across respondents.

        The tool also allows flexible recruitment of respondents specifically identified to best answer the research questions, without availability, language (multi-language function), or time zone concerns.

        Explore More

        Contact Us